Companies: 10,795·Total market cap: $144.5T
Fresh2 Group Limited

Fresh2 Group Limited

FRESNASDAQHealthcare
$0.85
$-0.26(-23.42%)
Market Cap$2084999
P/E Ratio
52W High$9.0
52W Low$0.7343

Fresh2 Group Limited (FRES) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

fres · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Fresh2 Group Limited (FRES) measures how much investors pay for each dollar of the company's trailing earnings. FRES's current PE ratio of N/A is calculated by dividing its stock price of $0.85 by its TTM earnings per share of -$106577.06.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E
0.06x
FY2024 est. EPS $14.60
Based on 1 analyst
EPS (TTM)
-$106577.06
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Fresh2 Group Limited SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2017 – 2022 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Fresh2 Group Limited
Fresh2 Group LimitedYou
FRES
$2MN/A-$106577.06
ASLAN Pharmaceuticals Limited
ASLAN Pharmaceuticals Limited
ASLN
$777MN/A-$10.75
Cutera, Inc.
Cutera, Inc.
CUTR
$2MN/A-$8.19
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc.
EIGRQ
$13MN/A-$50.78
Midatech Pharma plc
Midatech Pharma plc
MTP
$2MN/A-$0.00
Notable Labs, Ltd.
Notable Labs, Ltd.
NTBL
$2MN/A-$5.03
OncoSec Medical Incorporated
OncoSec Medical Incorporated
ONCSQ
$0MN/A-$19.13

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 6 of 6 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-12-31Latest
FY2022
$-106577.06
2021-12-31
FY2021
$-348964.38
2020-12-31
FY2020
$-287667.56
2019-12-31
FY2019
$-354559.17
2018-12-31
FY2018
$-147573.94
2017-12-31
FY2017
$-137094.34

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Fresh2 Group Limited (FRES) measures how much investors pay for each dollar of the company's trailing earnings. FRES's current PE ratio of N/A is calculated by dividing its stock price of $0.85 by its TTM earnings per share of -$106577.06.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.85 ÷ -$106577.06 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

FRES pe ratio · 6 questions

FRES's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.85 and TTM EPS of -$106577.06. Data sourced from Financial Modeling Prep via FRES's SEC 10-K and 10-Q filings.

FRES PE ratioWhat is FRES PE ratioCurrent PE ratio of FRESFRES PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Fresh2 Group Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09